WELLINGTON MANAGEMENT CO LLP 13D/13G Filings for Avidity Biosciences, Inc. (RNA)

WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Avidity Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-08
1:56 pm
Purchase
2024-09-3013GAvidity Biosciences, Inc.
RNA
WELLINGTON MANAGEMENT CO LLP7,030,949
5.970%
7,030,949increase
(New Position)
Filing